What Researchers Did
Researchers conducted a randomized controlled trial involving 63 healthy adults over 64 years old, assigning them to either hyperbaric oxygen therapy or a control group for three months to assess cognitive function and cerebral blood flow.
What They Found
They found a significant improvement in global cognitive function in the hyperbaric oxygen therapy group compared to the control group (p=0.0017). Specifically, attention (net effect size=0.745) and information processing speed (net effect size=0.788) showed the most striking enhancements, accompanied by increased cerebral blood flow in specific brain regions.
What This Means for Canadian Patients
For Canadian patients concerned about age-related cognitive decline, these findings suggest hyperbaric oxygen therapy could be a potential non-invasive intervention to improve attention and processing speed. However, more research is needed to determine its long-term benefits, accessibility, and cost-effectiveness within the Canadian healthcare system before widespread adoption.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
A limitation of this study is its relatively small sample size of 63 participants and the absence of long-term follow-up to assess the durability of cognitive improvements.